Alliance Pharma (GB:APH) has released an update.
Alliance Pharma Plc has experienced a significant shift in its shareholder structure, with DBAY Advisors Limited, acting as an investment manager for several entities, crossing a notable voting rights threshold. As of May 10, 2024, DBAY Advisors, through entities such as Logistics Development Group Plc and DouglasBay Capital IV Fund LP, now commands 22.66% of the voting rights in Alliance Pharma, an increase from a previous holding of 21.10%.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
